Skip to main content
Peptron, Inc. logo

Peptron, Inc. — Investor Relations & Filings

Ticker · 087010 ISIN · KR7087010005 KO Manufacturing
Filings indexed 226 across all filing types
Latest filing 2023-03-15 Transaction in Own Shar…
Country KR South Korea
Listing KO 087010

About Peptron, Inc.

http://www.peptron.com/

Peptron, Inc. is a biotechnology company specializing in peptide engineering and the development of sustained-release (SR) medications. The company's core focus is its proprietary SmartDepot platform technology, which enables the long-acting formulation of peptide-based drugs to treat chronic and life-threatening disorders. A key area of development is in neurodegenerative diseases, with a notable pipeline candidate being a sustained-release formulation of exenatide, based on patents exclusively licensed from the NIH. Peptron operates its own GMP-compliant manufacturing facility to produce its SR formulations, supporting its progression from pre-clinical research to commercial-stage development.

Recent filings

Filing Released Lang Actions
수시공시의무관련사항(공정공시)(자사주 취득 검토)
Transaction in Own Shares Classification · 100% confidence The document is a 'Fair Disclosure' (공정공시) announcement from Peptron regarding the company's intention to review and potentially execute a share buyback (자사주 취득). It outlines the purpose, estimated budget, and timeline for the buyback. Since it is an announcement of a future corporate action regarding share repurchase rather than the actual execution of a buyback or a formal regulatory filing for a specific share issue, it falls under the category of general regulatory announcements or corporate disclosures.
2023-03-15 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Peptron, detailing the date, location, and agenda items (financial statements, director compensation). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming votes, which falls under the Proxy Solicitation & Information Statement category.
2023-03-06 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Peptron. It contains the meeting agenda, details on voting procedures (including electronic voting), and financial statements (balance sheet, income statement, etc.) provided as reference materials for shareholders to review prior to the meeting. This document is a standard proxy solicitation and information statement sent to shareholders to inform them of the upcoming AGM and provide necessary materials for their vote.
2023-03-06 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, and proxy solicitation details. It also includes financial statements as part of the reference materials for shareholders. This document is a standard proxy solicitation statement used to request shareholder votes for an AGM.
2023-03-06 Korean
투자판단관련주요경영사항(파킨슨병 치료제(PT320)의 임상2a상 시험 결과보고서 수령)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Major Management Matter' disclosure regarding the receipt of a Phase 2a clinical trial result report for a Parkinson's disease drug (PT320). It details the trial methodology, results, and future plans. Since it is a specific regulatory disclosure of material information that does not fit into categories like financial reports or shareholder meetings, it is classified as a Regulatory Filing (RNS).
2022-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal notice regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It is a regulatory announcement concerning corporate governance and shareholder rights, which does not fit into specific categories like dividend announcements or financial reports. Given its nature as a regulatory disclosure regarding meeting preparation, it falls under the general regulatory filing category.
2022-12-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.